06 Dec, EOD - Indian

SENSEX 81709.12 (-0.07)

Nifty 50 24677.8 (-0.12)

Nifty Bank 53509.5 (-0.18)

Nifty IT 44716.05 (-0.20)

Nifty Midcap 100 58704.6 (0.45)

Nifty Next 50 73040.4 (0.76)

Nifty Pharma 22434.75 (-0.13)

Nifty Smallcap 100 19492.1 (0.82)

06 Dec, EOD - Global

NIKKEI 225 39091.17 (-0.77)

HANG SENG 19865.85 (1.56)

S&P 6096.25 (-0.07)

Login/Signup

You are Here : Home > Research

28-Oct-2023

Pfizer

PAT down 52.11%

'For the quarter ending Sept 2023, standalone Net sales (including other operating income) of Pfizer has declined 9.77% to Rs 575.21 crore compared to quarter ended Sept 2022.  Operating profit margin has declined from 36.35% to 31.75%, leading to 21.18% decline in operating profit to Rs 182.61 crore.  Raw material cost as a % of total sales (net of stock adjustments) decreased from 16.44% to 15.71%.   Purchase of finished goods cost rose from 11.67% to 14.84%.   Employee cost increased from 14.36% to 16.84%.   Other expenses rose from 17.19% to 18.38%.   

Other income up 48.80% to Rs 36.07 crore.  PBIDT fell 14.55% to Rs 218.68 crore.  Provision for interest fell 19.23% to Rs 2.73 crore.  Loan funds rose to Rs 42.63 crore as of 30 September 2023 from Rs 39.73 crore as of 30 September 2022.  Inventories declined from Rs 456.56 crore as of 30 September 2022 to Rs 399.08 cro...



Pleaselogin & subscribe to view the full report.

More Reports
More Reports View Company Information

  • Results-Analysis   (29-Oct-2024)

    Pfizer

    PAT up 6.3%

  • Results-Analysis   (30-Jul-2024)

    Pfizer

    OP increased 60.32%

  • Results-Analysis   (28-Oct-2023)

    Pfizer

    PAT down 52.11%

  • Results-Analysis   (16-May-2023)

    Pfizer

    PAT up 3.07%